A group used CRISPR-Cas9 for overexpression or knockdown of DCX (doublecortin), a protein associated with intracellular microtubules, in GBM cells showing that overexpression of DCX potentiated GBM proliferation while knockdown of it reduced cell proliferation significantly [74]. This evidence concerns the gene DCX and glioblastoma.